Histacin

Quick links to important sections

Histacin

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Histacin

Quick Facts

Property Description
Active ingredient Chlorphenamine maleate
Form Tablet, syrup, solution, injection
Pharmacological class First-generation H1-receptor antagonist
Common use Mitigate symptoms of allergic reactions
Origin Synthetic compound

What Type of Medicine is Histacin (Chlorphenamine)?

Histacin is a synthetic systemic agent centered on the active compound chlorphenamine maleate, which belongs to the alkylamine derivative chemical group. It is classified as a first-generation antihistamine and functions as an H1-receptor antagonist. This classification means the medication’s primary action is to reduce the effects of histamine released during an allergic response. This agent is clinically recognized for its established efficacy in acute allergy relief. Its designation as a first-generation agent confirms its long-standing use and characteristic structure among allergy medications, including its differentiation from newer agents by its structural features.

Composition, Forms, and General Therapeutic Purpose

The core purpose of Histacin is to mitigate the acute, symptomatic manifestations of allergic reactions and hypersensitivity by effectively blocking the action of histamine. The physiological action is realized when the chlorphenamine maleate prevents histamine from binding to and activating the body's target H1-receptors. This mechanism helps ease discomfort by stabilizing the body's response to allergens, such as relieving symptoms during a typical seasonal allergy flare-up. As a single-active ingredient product, Histacin is supplied in multiple pharmaceutical preparations, including the solid tablet form and liquid forms such as a syrup, a standard solution, and a preparation for injection. The diverse availability in forms utilizing either solid excipients or an aqueous vehicle ensures suitability for various patient needs, including pediatric patients and adults, allowing for either oral or parenteral route of administration.

Regulatory References

  1. National Institutes of Health (NIH)
  2. NIH: Inverse Agonism

What side effects are possible with Histacin?

Possible Side Effects and Safety Information

The official safety profile for Histacin (chlorphenamine maleate) primarily highlights effects related to Central Nervous System (CNS) depression and anticholinergic activity, as documented in regulatory sources such as the FDA Prescribing Information and European Summary of Product Characteristics (SmPC).


Adverse Reaction Classification

Adverse reactions are classified by frequency and System-Organ Class (SOC):

Classification Examples of Documented Effects
Very Common Sedation, somnolence (drowsiness)
Common Dizziness, dry mouth, blurred vision, headache, nausea
System-Organ Class Nervous System Disorders (e.g., psychomotor impairment), Gastrointestinal Disorders (e.g., constipation), Eye Disorders, Renal and Urinary Disorders (e.g., urinary retention)

Serious and Population-Specific Safety Notes

The regulatory profile lists rare but clinically significant adverse reactions, including severe blood dyscrasias (such as agranulocytosis and aplastic anaemia), hepatitis, jaundice, and the potential for anaphylactic reactions or convulsions.

Safety notes specify considerations for certain patient populations: Older adults may be more prone to anticholinergic effects and confusion. Children may experience paradoxical reactions, such as excitement or irritability. Caution is also advised for use in individuals with severe hepatic or renal impairment.

Safety limitations exist for individuals with pre-existing conditions like angle-closure glaucoma, conditions leading to urinary retention (e.g., prostatic hypertrophy), or epilepsy. The medicine is associated with the impairment of mental and physical abilities.

Overdose and Emergency Response

Histacin (chlorphenamine maleate) overdose is officially documented in regulatory prescribing information as potentially leading to severe, life-threatening outcomes that necessitate immediate medical attention.

Documented Overdose Manifestations

Overdose may present with serious Central Nervous System (CNS) effects, including severe sedation and somnolence, or paradoxically, CNS excitation, toxic psychosis, confusion, and convulsions (seizures). Documented life-threatening complications include cardiovascular collapse, cardiac arrhythmias, and apnoea (cessation of breathing).

Required Emergency Actions

Regulatory authorities mandate that any suspected overdose requires you to seek medical help right away or contact a Poison Control Center right away. Prompt medical attention is critical, even if initial symptoms are mild, due to the potential for rapid escalation to severe systemic instability.

Overdose Management and Specific Risks

Treatment is described as symptomatic and supportive, as no specific antidote is known. Officially described supportive procedures include considering the use of activated charcoal and the need to vigorously treat severe effects like hypotension and arrhythmias.

Regulatory information specifies that children and the elderly are more susceptible to the severe neurological anticholinergic effects and paradoxical excitation that can occur in overdose.

Therapeutic Uses of Histacin

What Histacin Treats: Main Uses and Benefits

Histacin is commonly used when short-term symptomatic assistance is needed, and may be part of symptomatic management for symptoms that may become intense or disruptive. It is applied in scenarios where additional management of discomfort is required and supports the patient during difficult episodes by easing distress.

The medication is commonly used across conditions presenting with acute episodes characterized by episodic or fluctuating manifestations, including allergic rhinitis (hay fever), hives (urticaria), symptoms of the mild common cold, and may be relevant for easing symptoms that interfere with routine activities, such as motion sickness.

Key Therapeutic Domains

This medication is relevant in contexts involving heightened systemic burden and is used in situations involving certain distressing symptoms related to inflammatory or irritative states. It offers symptomatic relief that supports the patient during difficult seasonal or episodic flare-ups, and assists with maintaining functional stability during symptomatic periods.

Quick Fact: Relief for Itching (Pruritus)

“Applied in contexts where additional symptomatic support is needed, Histacin contributes to improved comfort during periods of heightened symptoms.”

It is applied for managing symptoms related to inflammatory or irritative states that interfere with daily comfort, such as allergic skin itch and nausea associated with travel.

Eligibility and Restrictions for Use

Histacin (chlorphenamine maleate) eligibility is determined by strict regulatory criteria defined in official government labeling. The medicine is classified into populations that are contraindicated, restricted, or allowed for use.

Official Contraindications

Histacin must not be used by individuals with known hypersensitivity to chlorphenamine maleate or any of its components. It is also strictly contraindicated in patients who are currently using, or have used, a Monoamine Oxidase Inhibitor (MAOI) within the last 14 days.

Age-Related Eligibility and Restrictions

Age Group Eligibility Status (Oral Forms) Key Restriction/Note
Adults & Adolescents (12+ years) Established Use Standard labeled dose applies.
Children (under 6 years) Not Recommended Use of oral forms is generally not recommended.
Older Adults/Elderly Conditional Use Caution advised; greater susceptibility to neurological effects.

Conditional Use and Special Populations

Use is generally not recommended during pregnancy or lactation unless determined essential by a healthcare provider, due to potential risk. The medicine should be used with caution in patients with pre-existing conditions where anticholinergic effects may be detrimental, including glaucoma, prostatic hypertrophy (urinary retention), epilepsy, or severe hepatic (liver) or renal (kidney) impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation defines the interaction profile of Histacin (chlorphenamine maleate) primarily through pharmacodynamic reinforcement and pharmacokinetic interference, establishing specific co-administration restrictions.

Contraindicated Combinations and Restrictions

Concurrent therapy with Monoamine oxidase inhibitors (MAOIs) is contraindicated due to the risk of intensifying and prolonging the drug's antimuscarinic and sedative effects. This restriction applies for 14 days after stopping MAOI treatment. Co-administration must also be avoided with other antihistamine-containing products to prevent additive effects.

Documented Pharmacological Interactions

Interaction Type Interacting Substance/Category Officially Described Outcome
Pharmacodynamic CNS Depressants (e.g., sedatives, opioids, anxiolytics) and Alcohol (Ethanol) May enhance the sedative effects, leading to additive CNS depression.
Pharmacodynamic Antimuscarinic Drugs (e.g., tricyclic antidepressants) Results in enhanced antimuscarinic action.
Pharmacokinetic Phenytoin May inhibit the hepatic metabolism of phenytoin, creating a risk for phenytoin toxicity.

Population-Specific Notes

Caution is officially advised in patients with hepatic impairment, as slower clearance may increase the risk of neurological anticholinergic effects. Elderly patients are also noted as being more susceptible to these effects.

Mechanism of Action

How Histacin Works

Histacin is a highly selective compound that primarily functions by modulating key signaling pathways associated with histamine-mediated cellular signaling. It acts as a competitive antagonist at the histamine H1 receptor, the primary biological target for this agent. This interaction blocks the binding of the endogenous transmitter histamine, thereby suppressing the initiation of intracellular signaling cascades typically driven by H1 receptor activation.

This interference at the receptor level alters subsequent signaling events in relevant systems. By disrupting the primary activation signal, Histacin reduces the initiation signal resulting from high mediator concentrations, thereby attenuating downstream pathway activation and decreasing the magnitude of signal propagation. Specifically, the antagonistic effect suppresses the activation of Gq-protein coupled pathways, including the phospholipase C-IP3-Ca^2+ cascade. This mechanism shifts the targeted pathway toward a lower level of engagement and translates to an observable modification of processes influenced by H1-receptor stimulation.

Dosage and Administration Information

How Histacin (Chlorphenamine Maleate) Is Used

The usage of Histacin is defined by its approved forms, established dose limits, and specific administrative instructions. This medication is primarily intended for short-term symptomatic use on an as-needed basis, with continuous non-prescribed use generally limited to a maximum of two weeks.

Administration Routes and Forms

Histacin is administered via two primary pathways. The Oral (PO) route is common for outpatient use, utilizing immediate-release tablets (4 mg), syrup (2 mg/5 mL), and extended-release forms (8 mg or 12 mg). For acute clinical needs, the parenteral route is used, involving Intravenous (IV), Intramuscular (IM), or Subcutaneous (SC) injection of the 10 mg/ mL solution.

Dosing Frequency and Procedural Rules

The standard adult oral dose is 4 mg, which may be repeated every 4 to 6 hours, ensuring the total intake does not exceed 24 mg within a 24-hour period. Oral forms can be taken with or without food. The minimum interval between doses of the immediate-release form is strictly 4 hours.

Usage Constraint Instruction
Extended-Release Forms Must be swallowed whole; do not crush or chew.
IV Administration Must be injected slowly over a period of at least one minute.
Older Adults A lower daily maximum dose, such as 12 mg in 24 hours, is often considered.

Accurate dosing of liquid forms requires the use of an approved milliliter measuring device.

Recent Clinical Evidence

Histacin is an H1-antihistamine, a class of medications frequently used for the management of symptoms associated with allergic conditions such as seasonal allergic rhinitis (hay fever) and chronic urticaria (hives). Clinical research on this class of drug often focuses on comparing the efficacy and safety profile of newer agents (second-generation antihistamines) with older ones (first-generation antihistamines).


Second-Generation Antihistamines

Modern clinical studies indicate that second-generation H1-antihistamines are selective for peripheral histamine receptors and generally do not readily cross the blood-brain barrier. This characteristic is associated with a reduced potential for central nervous system (CNS) effects, such as drowsiness and cognitive impairment, when compared to first-generation agents. Trials have shown a favorable safety profile and comparable, or in some cases improved, relief of allergic symptoms when used for conditions like allergic rhinitis and chronic urticaria.


Evidence for Chronic Urticaria

For individuals with chronic spontaneous urticaria (CSU) whose symptoms persist despite initial treatment with H1-antihistamines, recent research has explored the role of newer targeted therapies as add-on treatments. For example, Phase 3 randomized, controlled trials for certain targeted biologic and small-molecule agents have reported significant reductions in weekly itch and hive scores when these drugs were administered alongside H1-antihistamines, compared to antihistamine treatment alone. These findings suggest evolving treatment strategies for patients who do not achieve sufficient control with standard antihistamine therapy alone. The overall body of evidence supports the continued role of Histacin and its class as a foundational treatment in allergic disease management.

Frequently Asked Questions (FAQ)

Common questions about Histacin (FAQ)

Q: Are there any common foods or drinks that should be avoided when taking Histacin?

Regulatory documents describe a constraint regarding alcohol consumption, also known as ethanol, while taking Histacin. This is because alcohol may enhance the sedative effects of the medication. The regulatory documents generally indicate that the oral forms of Histacin are described as being taken with or without food.


Q: Can older adults generally take Histacin safely?

A note of caution is included for the use of Histacin in older adults, according to official warnings. Regulatory sources indicate that this population is more susceptible to certain neurological and anticholinergic effects, such as confusion. The regulatory note may include a consideration for a lower daily maximum dose in this population.


Q: What kind of research has been done on Histacin?

Evidence supports Histacin’s mechanism of action as a potent first-generation H1 antihistamine, and it is described as being effective for acute allergy relief. Research often focuses on comparing its characteristics to newer antihistamines and evaluating its use as a foundational treatment for chronic urticaria (hives).


Q: Does Histacin interact with cold and flu remedies?

Official warnings state a constraint regarding co-administration of Histacin with other products that contain antihistamines. Since many non-prescription cold and flu remedies contain antihistamines, combining these products is contraindicated due to the risk of additive effects and excessive sedation.


Q: Why do some sources mention different uses for Histacin?

Histacin is approved by regulatory agencies for various symptomatic treatments related to allergy and hypersensitivity reactions. The official drug labels list multiple approved uses, which can include allergic rhinitis (hay fever), conjunctivitis, urticaria (hives), and use as an adjunct in the emergency management of anaphylactic reactions.


Q: What information is usually given to patients about Histacin research?

Patient-facing materials generally communicate that Histacin is a long-standing first-generation H1-antihistamine. This information establishes that the drug is recognized to work by blocking histamine, and it is used for the symptomatic relief of allergic reactions.


Q: What are the signs of a serious or rare side effect of Histacin?

Official documents list rare but serious adverse reactions, which include signs of severe blood disorders, such as unusual weakness or easy bruising. Other reported reactions include symptoms of hepatitis, such as jaundice (yellowing of the skin or eyes), and signs of an allergic reaction like swelling or difficulty breathing.


Q: Does Histacin interact with psychiatric medications like SSRIs?

Regulatory information includes a note of caution regarding the concurrent use of Histacin with certain classes of psychiatric medications, including central nervous system (CNS) depressants and antidepressants like SSRIs. Combining these medications may enhance the sedative or anticholinergic effects of Histacin.


Q: What are the main research findings related to Histacin?

Research establishes the active ingredient in Histacin as a potent alkylamine H1 antihistamine. Evidence indicates its role in providing symptomatic relief for allergic conditions. The medication's class is supported as a foundational treatment in standard allergy management.


Q: Are there any non-prescription products that interact with Histacin?

Yes, regulatory documents explicitly state a constraint regarding the use of alcohol while taking Histacin. Furthermore, co-administration with other antihistamine-containing products is described as constrained, as many of these are available without a prescription and could increase the risk of side effects.


Q: How quickly does Histacin usually start to work?

According to official pharmacokinetic data, the onset of action for Histacin is reported to occur within two hours of taking an oral dose. Maximum concentrations of the drug in the blood are usually reached between 2.5 and 6 hours after administration.


Q: Is Histacin available over the counter, or does it require a prescription?

The regulatory status of Histacin varies by country. In several major markets, including the United States, it is classified as a Human OTC Drug, meaning it can be purchased without a prescription. Other regions may classify it as a Pharmacy Medicine.


Q: What happens if I miss a dose of Histacin?

Standard guidance for this medication describes a procedure where missed doses are typically skipped rather than compensated for. The next administration is intended to occur at its regularly scheduled time.


Q: What is the typical duration of the effects of Histacin after a single dose?

The reported duration of action for an immediate-release dose of Histacin is typically between four and six hours. The regulatory constraint specifies that a subsequent dose should only be taken after a minimum interval of four hours.


Q: Does Histacin affect blood pressure?

Official regulatory documents list both hypotension (low blood pressure) and hypertension (high blood pressure) among the rare or uncommon adverse effects. The official label includes a note of caution for using the medication in patients who have pre-existing severe hypertension or cardiovascular disease.


Q: Can Histacin be taken with common pain relievers like ibuprofen or acetaminophen?

Patient guidance derived from official data generally indicates that official data does not indicate a known adverse interaction between Histacin and common non-opioid pain relievers. This includes products containing active ingredients like acetaminophen (paracetamol) or ibuprofen.


Q: Is there a generic version of Histacin available?

Yes, the active ingredient in Histacin, which is chlorpheniramine maleate, is widely available as a generic medication. It is listed under numerous generic product labels by regulatory agencies worldwide.


Q: Are there any known interactions between Histacin and herbal supplements?

Official patient guidance includes a recommendation to consult a healthcare provider regarding co-administration with herbal supplements. This is relevant for supplements that may cause effects like drowsiness, dry mouth, or difficulty urinating, as the combined effects could be enhanced.


Q: Can taking Histacin impact the results of allergy skin tests?

Yes, like other antihistamines, Histacin is known to inhibit the immediate skin reaction to an allergen used in diagnostic skin tests. Regulatory warnings describe a required wash-out period, often several days, before a patient undergoes allergy skin testing.


Q: Is there a risk of dependence or withdrawal with Histacin?

Single-ingredient Histacin is not a controlled substance, and regulatory labels do not list dependence or withdrawal as typical adverse effects of this specific medication. However, it is noted that the drug is sometimes combined with other medications, such as opioids, that do carry a risk of dependence.


Q: Does Histacin have a 'black box' warning on its regulatory label?

Based on a review of official prescribing information from regulatory agencies like the FDA, the single-ingredient product Histacin (chlorpheniramine maleate) is not required to carry a 'black box' warning.


Q: Is Histacin a steroid?

No, Histacin is not classified as a steroid. It is classified as a first-generation H1-receptor antagonist, which places it in the antihistamine class of medications.


Q: How long does it take for Histacin's side effects to stop if I discontinue use?

The time required for the body to fully clear the medication and its side effects varies widely among individuals. Official pharmacokinetic data reports the elimination half-life (the time it takes for half the drug to be eliminated) to be approximately 14 to 43 hours.


Q: Is Histacin approved in multiple countries for the same uses?

Yes, the active ingredient in Histacin is approved and used across numerous international jurisdictions, including North America, Europe, and Australia. In these regions, it is primarily approved for the symptomatic relief of allergic conditions.

How should Histacin be stored and disposed of?

Histacin (chlorphenamine maleate) must be stored and handled according to specific regulatory requirements to maintain its stability and effectiveness.

Official Storage Requirements

Condition Requirement
Temperature Store below 25 C or 30 C (room temperature), depending on the formulation. Do not freeze.
Protection The product must be protected from light and kept in a dry location.
Container Store in the original container/packaging and ensure the container is tightly closed.

Child Safety and Disposal

The medication must always be stored out of the sight and reach of children.

Unused or expired Histacin product must be disposed of according to local regulatory requirements and should not be discarded into wastewater or standard household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Histacin found in:

A-Z Index: